Companies: 10,795·Total market cap: $144.5T
Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTUNASDAQHealthcare● Active
$1.82
$-0.06(-3.19%)
Market Cap$43545051
P/E Ratio
52W High$9.35
52W Low$1.58

Actuate Therapeutics Inc (ACTU) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · ACTU · as of Sep 30, 2025

Ownership Breakdown

42

Institutional Holders

▲ 4 vs Q2

$80.46M

Total Inst. Value

▲ $11.91M vs Q2

Shares Outstanding

12.03M

13F Shares Held

▲ 808,930 vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

No institutional data available for this period.

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

16

Increased

+903.8K shares

6

New Positions

first time holders

12

Decreased

−86.1K shares

2

Sold Out

fully exited

Net shares change (top 50)

+817.7K

+903.8K / −86.1K

Net new holders

+8

6 new / 2 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

ACTU insider trading · insider activity

Source: SEC Form 4

Recent Insider Transactions

Showing 10 most recent · Common Stock only

No recent insider transactions reported.

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Actuate Therapeutics Inc (ACTU) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.

A total of 42 institutional investors currently hold ACTU stock, with a combined institutional value of approximately $80,455,749 as of the most recent 13F filing period.

Frequently asked questions

ACTU ownership

Actuate Therapeutics Inc (ACTU) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of September 30, 2025.

who owns ACTU stockACTU ownership structureSEC Form 13F institutional holdingsACTU float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025